Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Cancer. 2011 Jan 18;117(15):3374–3382. doi: 10.1002/cncr.25852

Table 5.

Grade 1–4 toxicities in patients treated with bortezomib plus doxorubicin (N=12)

Toxicity Grade 1 Grade 2 Grade 3 Grade 4
Anemia 9 1 - -
Lymphopenia - 1 1 -
Neutropenia 1 2 2 1
Thrombocytopenia 7 - - -
Fatigue 4 6 - -
Fever without neutropenia 1 - - -
Rigors/chills 1 1 - -
Weight loss 1 2 - -
Alopecia 6 1 - -
Injection site reaction 1 - - -
Rash/desquamation 3 1 - -
Anorexia 2 2 2 -
Constipation 4 1 - -
Diarrhea without prior colostomy 3 1 1 -
Dry mouth 1 - - -
Gastritis 1 - - -
Dyspepsia 1 - - -
Stomatitis by exam 3 1 - -
Stomatitis (symptom) 4 1 - -
Nausea 7 2 - -
Obstruction, ileum 1 - - -
Vomiting 2 1 - -
Stoma, upper respiratory hemorrhage 1 - - -
Infection with grade 0–2 neutropenia, upper airway - 1 - -
Edema, head and neck 1 - - -
Elevated alkaline phosphatase 3 1 - -
Elevated ALT 1 - 1 -
Elevated AST - - - 1
Elevated bilirubin - - 1 -
Elevated gamma-glutamyl transferase - 1 - -
Hypokalemia 1 - - -
Hyponatremia 2 - - -
Neuropathy, cranial nerve VII 1 - - -
Neuropathy, cranial nerve XII 1 - - -
Neuropathy-sensory 3 1 - -
Dry eye syndrome 1 - - -
Vision-blurred 1 - - -
Tearing 1 - - -
Abdominal pain 1 - 1 -
Chest pain 1 - - -
Esophageal pain 1 - - -
Facial pain 1 - - -
Headache 1 - - -
Joint pain 1 - - -
Neck pain 1 - - -
Oral cavity pain 1 - - -
Pain, not otherwise specified 1 - - -
Cough 1 - - -
Dyspnea 1 - - -

One patient is missing toxicity data in step 2